ScanSource (SCSC) director buys 3,693 shares, ownership hits 35,893
Insider purchase reported: Temple Elizabeth Orazem, a director of ScanSource, Inc. (SCSC), acquired 3,693 shares of the company's common stock on 09/01/2025 at no cash price reported, leaving her with 35,893 shares beneficially owned.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Insider purchase reported: Temple Elizabeth Orazem, a director of ScanSource, Inc. (SCSC), acquired 3,693 shares of the company's common stock on 09/01/2025 at no cash price reported, leaving her with 35,893 shares beneficially owned. The Form 4 shows the acquisition was a direct purchase and the filing was signed by an attorney-in-fact.
Insights
TL;DR: A director increased direct holdings by 3,693 shares, modestly raising insider ownership to 35,893 shares.
The transaction is a straightforward, non-derivative acquisition recorded on the Form 4. The purchase increases the director's direct stake, which can signal confidence but is small relative to typical company market caps. No price was reported on the form (listed as $0.00), and no derivative transactions or dispositions accompany this filing.
TL;DR: Director's direct purchase is a routine insider transaction with limited immediate governance implications.
The form indicates compliance with Section 16 reporting by disclosing the acquisition and resulting beneficial ownership. There are no indications of option exercises, plan-related transactions, or changes to ownership structure beyond the incremental share increase. The filing was executed by an attorney-in-fact, which is a common administrative practice.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,693 | $0.00 | $0.00 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Was the Form 4 for SCSC a purchase or a sale?
Did the filing report any derivative transactions for SCSC?
Who signed the SCSC Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.